Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Modified Glasgow prognostic score (mGPS) is correlated with sarcopenia and dominates the prognostic role of baseline body composition parameters in advanced gastric and esophagogastric junction cancer patients undergoing first-line treatment from the phase III EXPAND trial.
Hacker UT, Hasenclever D, Baber R, Linder N, Busse H, Obermannova R, Zdrazilova-Dubska L, Valik D, Lordick F. Hacker UT, et al. Ann Oncol. 2022 Jul;33(7):685-692. doi: 10.1016/j.annonc.2022.03.274. Epub 2022 Apr 5. Ann Oncol. 2022. PMID: 35395383 Free article. Clinical Trial.
[Current standards in the treatment of gastric cancer].
Hacker U, Lordick F. Hacker U, et al. Dtsch Med Wochenschr. 2015 Aug;140(16):1202-5. doi: 10.1055/s-0041-102756. Epub 2015 Aug 11. Dtsch Med Wochenschr. 2015. PMID: 26261926 Review. German.
[Current standards in the treatment of gastric cancer].
Hacker U, Lordick F. Hacker U, et al. Dtsch Med Wochenschr. 2015 Sep;140(19):1417. doi: 10.1055/s-0041-106868. Epub 2015 Sep 24. Dtsch Med Wochenschr. 2015. PMID: 26402172 German. No abstract available.
[Weight loss in cancer patients].
Lordick F, Hacker U. Lordick F, et al. Dtsch Med Wochenschr. 2016 Feb;141(4):247-52. doi: 10.1055/s-0041-107943. Epub 2016 Feb 17. Dtsch Med Wochenschr. 2016. PMID: 26886037 German.
Randomised phase II trial to investigate catumaxomab (anti-EpCAM × anti-CD3) for treatment of peritoneal carcinomatosis in patients with gastric cancer.
Knödler M, Körfer J, Kunzmann V, Trojan J, Daum S, Schenk M, Kullmann F, Schroll S, Behringer D, Stahl M, Al-Batran SE, Hacker U, Ibach S, Lindhofer H, Lordick F. Knödler M, et al. Br J Cancer. 2018 Aug;119(3):296-302. doi: 10.1038/s41416-018-0150-6. Epub 2018 Jul 10. Br J Cancer. 2018. PMID: 29988111 Free PMC article. Clinical Trial.
High prevalence of severe hypovitaminosis D in patients with advanced gastric cancer treated with first-line chemotherapy with or without anti-EGFR-directed monoclonal antibody (EXPAND trial) showing no prognostic impact.
Obermannova R, Valik D, Hasenclever D, Zdrazilova-Dubska L, Hacker U, Demlova R, Selingerova I, Lordick F. Obermannova R, et al. Eur J Cancer. 2019 Jul;116:107-113. doi: 10.1016/j.ejca.2019.05.011. Epub 2019 Jun 10. Eur J Cancer. 2019. PMID: 31195354 Clinical Trial.
77 results